ORIGINAL REPORTS
Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor–Positive, Metastatic Carcinoma of the Breast in Premenopausal Women
Robert. W. Carlson, Richard Theriault, Christine M. Schurman, Edgardo Rivera, Cathie T. Chung, See-Chun Phan, Banu Arun, Kristine Dice, Vivian Y. Chiv, Marjorie Green, and Vicente Valero JCO Sep 1, 2010:3917-3921; published online on August 2, 2010;10.1200/JCO.2009.24.9565. [Abstract] [Full Text] [PDF]
Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Javier Cortes, Linda Vahdat, Joanne L. Blum, Chris Twelves, Mario Campone, Henri Roché, Thomas Bachelot, Ahmad Awada, Robert Paridaens, Anthony Goncalves, Dale E. Shuster, Jantien Wanders, Fang Fang, Renuka Gurnani, Elaine Richmond, Patricia E. Cole, Simon Ashworth, and Mary Ann Allison JCO Sep 1, 2010:3922-3928; published online on August 2, 2010;10.1200/JCO.2009.25.8467. [Abstract] [Full Text] [PDF]
Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32
Stephanie R. Land, Jacek A. Kopec, Thomas B. Julian, Ann M. Brown, Stewart J. Anderson, David N. Krag, Nicholas J. Christian, Joseph P. Costantino, Norman Wolmark, and Patricia A. Ganz JCO Sep 1, 2010:3929-3936; published online on August 2, 2010;10.1200/JCO.2010.28.2491. [Abstract] [Full Text] [PDF] [Data Supplement]
Epirubicin, Oxaliplatin, and Capecitabine With or Without Panitumumab for Advanced Esophagogastric Cancer: Dose-Finding Study for the Prospective Multicenter, Randomized, Phase II/III REAL-3 Trial
Alicia F.C. Okines, Sue E. Ashley, David Cunningham, Jacqueline Oates, Andrea Turner, Janine Webb, Claire Saffery, Yu Jo Chua, and Ian Chau JCO Sep 1, 2010:3945-3950; published online on August 2, 2010;10.1200/JCO.2010.29.2847. [Abstract] [Full Text] [PDF]
ASCO SPECIAL ARTICLE
Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting
Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Jacques Belghiti, Steven Curley, Yuman Fong, Gregory Gores, Robert Kerlan, Phillipe Merle, Bert O'Neil, Ronnie Poon, Lawrence Schwartz, Joel Tepper, Francis Yao, Daniel Haller, Margaret Mooney, and Alan Venook JCO Sep 1, 2010:3994-4005; published online on August 2, 2010;10.1200/JCO.2010.28.7805. [Abstract] [Full Text] [PDF]
Volume 28, Issue 27 - September 20, 2010
ORIGINAL REPORTS
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
Dawn L. Hershman, Lawrence H. Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, and Alfred I. Neugut JCO Sep 20, 2010:4120-4128; published online on June 28, 2010;10.1200/JCO.2009.25.9655. [Abstract] [Full Text] [PDF]
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
Danny Rischin, Richard J. Young, Richard Fisher, Stephen B. Fox, Quynh-Thu Le, Lester J. Peters, Ben Solomon, Jimin Choi, Brian O'Sullivan, Lizbeth M. Kenny, and Grant A. McArthur JCO Sep 20, 2010:4142-4148; published online on August 9, 2010;10.1200/JCO.2010.29.2904. [Abstract] [Full Text] [PDF]
Phase III Trial of Carboplatin Plus Paclitaxel With or Without Gemcitabine in First-Line Treatment of Epithelial Ovarian Cancer
Andreas du Bois, Jørn Herrstedt, Anne-Claire Hardy-Bessard, Hans-Helge Müller, Philipp Harter, Gunnar Kristensen, Florence Joly, Jens Huober, Elisabeth Åvall-Lundqvist, Béatrice Weber, Christian Kurzeder, Svetislav Jelic, Eric Pujade-Lauraine, Alexander Burges, Jacobus Pfisterer, Martina Gropp, Anne Staehle, Pauline Wimberger, Christian Jackisch , and Jalid Sehouli JCO Sep 20, 2010:4162-4169; published online on August 23, 2010;10.1200/JCO.2009.27.4696. [Abstract] [Full Text] [PDF]
Control of Plasma Uric Acid in Adults at Risk for Tumor Lysis Syndrome: Efficacy and Safety of Rasburicase Alone and Rasburicase Followed by Allopurinol Compared With Allopurinol Alone—Results of a Multicenter Phase III Study
Jorge Cortes, Joseph O. Moore, Richard T. Maziarz, Meir Wetzler, Michael Craig, Jeffrey Matous, Selina Luger, Bimalangshu R. Dey, Gary J. Schiller, Dat Pham, Camille N. Abboud, Muthuswamy Krishnamurthy, Archie Brown, Jr, Abderrahmane Laadem, and Karen Seiter JCO Sep 20, 2010:4207-4213; published online on August 16, 2010;10.1200/JCO.2009.26.8896. [Abstract] [Full Text] [PDF]
Impact of Short-Course Preoperative Radiotherapy for Rectal Cancer on Patients' Quality of Life: Data From the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 Randomized Clinical Trial
Richard J. Stephens, Lindsay C. Thompson, Phil Quirke, Robert Steele, Robert Grieve, Jean Couture, Gareth O. Griffiths , and David Sebag-Montefiore JCO Sep 20, 2010:4233-4239; published online on June 28, 2010;10.1200/JCO.2009.26.5264. [Abstract] [Full Text] [PDF]
Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer
Diane Lauren Reidy, Efsevia Vakiani, Marwan G. Fakih, Muhammad Wasif Saif, Joel Randolph Hecht, Noah Goodman-Davis, Ellen Hollywood, Jinru Shia, Jonathan Schwartz, Kumari Chandrawansa, Aruna Dontabhaktuni, Hagop Youssoufian, David B. Solit, and Leonard B. Saltz JCO Sep 20, 2010:4240-4246; published online on August 16, 2010;10.1200/JCO.2010.30.4154. [Abstract] [Full Text] [PDF]
Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer
Kim N. Chi, Sebastien J. Hotte, Evan Y. Yu, Dongsheng Tu, Bernhard J. Eigl, Ian Tannock, Fred Saad, Scott North, Jean Powers, Martin E. Gleave, and Elizabeth A. Eisenhauer JCO Sep 20, 2010:4247-4254; published online on August 23, 2010;10.1200/JCO.2009.26.8771. [Abstract] [Full Text] [PDF]
